Lehfilcon A multifocal contact lenses
DeviceInvestigational frequent replacement soft contact lens indicated for the optical correction of presbyopia
Other names: LID210464
NCT Number: NCT05338333
The primary objective of this study is to demonstrate noninferiority in visual acuity at distance when wearing the test contact lenses (LID210464) compared to the control contact lenses (AOHG MF) after 30 days of wear.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Kindred Optics at Maitland Vision, Maitland, Florida, United States
Subjects will be expected to attend 4 office visits and will be dispensed study contact lenses (test lenses and control lenses) for a 30-day duration of bilateral wear for each study lens type (total of approximately 60 days of contact lens wear).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
Investigational frequent replacement soft contact lens indicated for the optical correction of presbyopia
Other names: LID210464
Commercially available frequent replacement soft contact lens indicated for the optical correction of presbyopia
Other names: AOHG MF, AIR OPTIX® plus HydraGlyde® Multifocal (AOHG MF) contact lenses
Hydrogen peroxide-based contact lens cleaning and disinfecting solution
Time frame: Day 30, each wear period. A wear period was approximately 30 days.
Visual acuity (VA) was assessed with study lenses in place under high contrast, high illumination. VA was collected for both eyes together using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details